Lipella Pharmaceuticals Inc. (LIPO)

USD 2.61

(-3.69%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue 449.61 Thousand 184.15 Thousand 259.34 Thousand 961.68 Thousand 694.74 Thousand
Cost of Revenue 3.03 Million 2.54 Million 1.45 Million 975.96 Thousand 682.89 Thousand
Gross Profit -2.58 Million -2.36 Million -1.19 Million -14.27 Thousand 11.85 Thousand
Operating Expenses 2.15 Million 2.77 Million 2.17 Million 1.01 Million 748.53 Thousand
Selling, General and Administrative Expenses 2.15 Million 226.19 Thousand 718.38 Thousand 42.58 Thousand 65.64 Thousand
Research and Development Expenses 3.03 Million 2.54 Million 1.45 Million 975.96 Thousand 682.89 Thousand
Other Expenses - -45.00 57.08 Thousand - -
Cost and Expenses 5.19 Million 2.77 Million 2.17 Million 1.01 Million 748.53 Thousand
Operating Income -4.74 Million -2.58 Million -1.91 Million -56.86 Thousand -53.79 Thousand
Interest Expense 10.84 Thousand 9612.00 6834.00 7965.00 8391.00
Income Tax Expense - -1633.00 6730.00 4794.00 -53.79 Thousand
Earnings before Tax -4.61 Million -2.59 Million -1.86 Million -61.65 Thousand -61.84 Thousand
Net Income -4.61 Million -2.59 Million -1.87 Million -66.45 Thousand -61.84 Thousand
Earnings Per Share Basic -0.77 -0.45 -0.33 -0.01 -0.01
Earnings Per Share Diluted -0.77 -0.45 -0.33 -0.01 -0.01
Weighted Average Shares Outstanding 6 Million 5.74 Million 5.74 Million 5.69 Million 5.69 Million
Weighted Average Shares Outstanding (Diluted) 6 Million 5.74 Million 5.74 Million 5.69 Million 5.69 Million
Gross Margin -5.76 -12.83 -4.62 -0.01 0.02
EBIT Margin -10.25 -14.05 -7.17 -0.06 -0.08
Profit Margin -10.27 -14.10 -7.22 -0.07 -0.09
EBITDA -4.6 Million -2.58 Million - -53.69 Thousand 334.00
Earnings Before Tax Margin -10.56 -14.06 -7.39 -0.06 -0.08

Income Statement Charts